Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, Biocon has informed that it enclosed the Monitoring Agency Reports dated May 07, 2026 issued by India Ratings & Research, Monitoring Agency, in respect of utilisation of proceeds raised through Qualified Institutions Placements by the Company, for the quarter ended March 31, 2026. The Audit Committee and Board of Directors of the Company have reviewed and took note of the Monitoring Agency Reports at their respective meetings held on May 07, 2026. The above-mentioned information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
